To address the implementation of the Lab for Innovation in Chronic Conditions in Santo Antonio do Monte, indicating the main challenges and lessons of a new chronic condition model.This is an observational study based on two sources of data: 1) two cross-sectional household surveys, 2013 (2012 as reference year) and 2015 (2014 as reference year), representative for the entire population and four target groups (pregnant women; children under two years old; individuals with hypertension and diabetes); medical records of individuals who self-reported having hypertension or diabetes in the household survey of 2013. A descriptive statistics analysis was performed.
IC Multi Elem (3) Anion Std F PO4 Br 1000ppm in H2O - 100ML |
|||
| ICA3-SER | Scientific Laboratory Supplies | 100ML | EUR 243.82 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (HRP) |
|||
| MBS6153302-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (HRP) |
|||
| MBS6153302-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (AP) |
|||
| MBS6132090-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (AP) |
|||
| MBS6132090-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) APC |
|||
| MBS6137393-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) APC |
|||
| MBS6137393-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Galectin-8, ID (LGALS8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, Prostate Carcinoma Tumor Antigen 1, PCTA-1) |
|||
| MBS6003138-005mg | MyBiosource | 0.05(mg | EUR 745 |
Galectin-8, ID (LGALS8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, Prostate Carcinoma Tumor Antigen 1, PCTA-1) |
|||
| MBS6003138-5x005mg | MyBiosource | 5x0.05mg | EUR 3195 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (PE) |
|||
| MBS6158605-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (PE) |
|||
| MBS6158605-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (Biotin) |
|||
| MBS6142696-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (Biotin) |
|||
| MBS6142696-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (FITC) |
|||
| MBS6147999-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (FITC) |
|||
| MBS6147999-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Polyphosphoric acid approx. 84% P2O5 |
|||
| P21930 | Pfaltz & Bauer | 250G | EUR 124.2 |
|
Description: CAS N° 8017-16-1 |
|||
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 550) |
|||
| MBS6212303-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 550) |
|||
| MBS6212303-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 405) |
|||
| MBS6190953-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 405) |
|||
| MBS6190953-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 750) |
|||
| MBS6233653-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 750) |
|||
| MBS6233653-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 490) |
|||
| MBS6201628-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 490) |
|||
| MBS6201628-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 650) |
|||
| MBS6222978-01mL | MyBiosource | 0.1(mL | EUR 875 |
LGALS8 (Galectin-8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1) (MaxLight 650) |
|||
| MBS6222978-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Src Homology-2 (SH2) Domain Ligand [Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu] |
|||
| MBS658205-1mg | MyBiosource | 1mg | EUR 610 |
Src Homology-2 (SH2) Domain Ligand [Ac-Tyr(PO3H2)-Tyr(PO3H2)-Tyr(PO3H2)-Ile-Glu] |
|||
| MBS658205-5x1mg | MyBiosource | 5x1mg | EUR 2600 |
(Ser(PO3H2)202,Thr(PO3H2)205)-Tau Peptide (194-213) |
|||
| H-8166.0500 | Bachem | 0.5mg | EUR 360 |
|
Description: Sum Formula: C81H133N29O36P2; CAS# [2022956-55-2] net |
|||
(Ser(PO3H2)202,Thr(PO3H2)205)-Tau Peptide (194-213) |
|||
| H-8166.1000 | Bachem | 1.0mg | EUR 594 |
|
Description: Sum Formula: C81H133N29O36P2; CAS# [2022956-55-2] net |
|||
2-hydroxyisobutyryllysine (SDT-R439_P2O1) |
|||
| S01012S | Starter Biotechnology Co Ltd | 500 mL | Ask for price |
IC Multi Elem (3) Std PO4 100ug/mL NH4 NO3 1000ug/mL - 500ML |
|||
| ICA-TG-35 | Scientific Laboratory Supplies | 500ML | EUR 348.11 |
IC Multi Elem (3) Anion Std F NO2 PO4 100mg/L in H2O - 250ML |
|||
| ICA-MX3-250 | Scientific Laboratory Supplies | 250ML | EUR 484.7 |
Kinesis Rotor Seal; 5-Pos. 7-Port; 1200 BarAgilent - EACH |
|||
| CHR6450 | Scientific Laboratory Supplies | EACH | EUR 973.81 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (AP) |
|||
| MBS6447537-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (AP) |
|||
| MBS6447537-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (PE) |
|||
| MBS6447547-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (PE) |
|||
| MBS6447547-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (AP) |
|||
| MBS6424648-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (AP) |
|||
| MBS6424648-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (PE) |
|||
| MBS6424658-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (PE) |
|||
| MBS6424658-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (APC) |
|||
| MBS6447538-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (APC) |
|||
| MBS6447538-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (FITC) |
|||
| MBS6447540-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (FITC) |
|||
| MBS6447540-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (HRP). |
|||
| MBS6447541-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (HRP). |
|||
| MBS6447541-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (APC) |
|||
| MBS6424649-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (APC) |
|||
| MBS6424649-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (FITC) |
|||
| MBS6424651-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (FITC) |
|||
| MBS6424651-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (HRP) |
|||
| MBS6424652-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (HRP) |
|||
| MBS6424652-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (Biotin) |
|||
| MBS6447539-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (Biotin) |
|||
| MBS6447539-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (Biotin) |
|||
| MBS6424650-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (Biotin) |
|||
| MBS6424650-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 405) |
|||
| MBS6447542-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 405) |
|||
| MBS6447542-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 490) |
|||
| MBS6447543-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 490) |
|||
| MBS6447543-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 550) |
|||
| MBS6447544-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 550) |
|||
| MBS6447544-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 650) |
|||
| MBS6447545-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 650) |
|||
| MBS6447545-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 750) |
|||
| MBS6447546-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 750) |
|||
| MBS6447546-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 405) |
|||
| MBS6424653-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 405) |
|||
| MBS6424653-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 490) |
|||
| MBS6424654-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 490) |
|||
| MBS6424654-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 550) |
|||
| MBS6424655-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 550) |
|||
| MBS6424655-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 650) |
|||
| MBS6424656-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 650) |
|||
| MBS6424656-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 750) |
|||
| MBS6424657-01mL | MyBiosource | 0.1mL | EUR 950 |
LGALS8 (Galectin-8, Gal-8, Prostate Carcinoma Tumor Antigen 1, PCTA1, PCTA-1, Po66-CBP) (MaxLight 750) |
|||
| MBS6424657-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
3PO |
|||
| 407325 | MedKoo Biosciences | 100.0mg | EUR 150 |
3PO |
|||
| abx283073-100g | Abbexa | 100 µg | Ask for price |
3PO |
|||
| abx283073-20g | Abbexa | 20 µg | EUR 106.25 |
3PO |
|||
| abx283073-50g | Abbexa | 50 µg | EUR 262.5 |
3PO |
|||
| B4939-10 | ApexBio | 10 mg | EUR 64 |
|
Description: Others|Others |
|||
3PO |
|||
| B4939-100 | ApexBio | 100mg | EUR 304 |
|
Description: Others|Others |
|||
3PO |
|||
| B4939-25 | ApexBio | 25 mg | EUR 230.4 |
3PO |
|||
| B4939-5 | ApexBio | 5mg | EUR 40 |
|
Description: Others|Others |
|||
3PO |
|||
| B4939-50 | ApexBio | 50mg | EUR 168 |
|
Description: Others|Others |
|||
3PO |
|||
| B2018-10 | Biovision | each | EUR 183.6 |
3PO |
|||
| HY-19824 | MedChemExpress | 10mg | EUR 271.65 |
|
Description: 3PO is an inhibitor of PFKFB3. 3PO attenuates the proliferation of several cancer cell lines with IC50s of 1.4-24 μmol/L. 3PO suppresses glucose uptake and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+ and NADH. 3PO can be used for the research of cancer[1]. |
|||
3PO |
|||
| MBS3601318-100mg | MyBiosource | 100mg | EUR 605 |
3PO |
|||
| MBS3601318-10mg | MyBiosource | 10mg | EUR 235 |
3PO |
|||
| MBS3601318-25mg | MyBiosource | 25mg | EUR 295 |
3PO |
|||
| MBS3601318-50mg | MyBiosource | 50mg | EUR 390 |
3PO |
|||
| MBS3601318-5mg | MyBiosource | 5mg | EUR 215 |
3PO |
|||
| MBS385198-100mg | MyBiosource | 100mg | EUR 345 |
3PO |
|||
| MBS385198-25mg | MyBiosource | 25mg | EUR 165 |
3PO |
|||
| MBS385198-50mg | MyBiosource | 50mg | EUR 230 |
3PO |
|||
| MBS385198-5x100mg | MyBiosource | 5x100mg | EUR 1550 |
3PO |
|||
| MBS5764836-100mg | MyBiosource | 100mg | EUR 350 |
3PO |
|||
| MBS5764836-10mg | MyBiosource | 10mg | EUR 160 |
3PO |
|||
| MBS5764836-200mg | MyBiosource | 200mg | EUR 495 |
3PO |
|||
| MBS5764836-50mg | MyBiosource | 50mg | EUR 250 |
3PO |
|||
| MBS5764836-5mg | MyBiosource | 5mg | EUR 145 |
3PO |
|||
| MBS578312-10mg | MyBiosource | 10mg | EUR 170 |
3PO |
|||
| MBS578312-25mg | MyBiosource | 25mg | EUR 225 |
3PO |
|||
| MBS578312-2mg | MyBiosource | 2mg | EUR 135 |
3PO |
|||
| MBS578312-50mg | MyBiosource | 50mg | EUR 325 |
3PO |
|||
| MBS578312-5mg | MyBiosource | 5mg | EUR 150 |
(E)-3PO |
|||
| T3260-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: (E)-3PO |
|||
(E)-3PO |
|||
| T3260-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: (E)-3PO |
|||
(E)-3PO |
|||
| T3260-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: (E)-3PO |
|||
(E)-3PO |
|||
| T3260-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: (E)-3PO |
|||
(E)-3PO |
|||
| T3260-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: (E)-3PO |
|||
3PO |
|||
| T22223-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: 3PO |
|||
3PO |
|||
| T22223-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: 3PO |
|||
3PO |
|||
| T22223-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: 3PO |
|||
3PO |
|||
| T22223-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: 3PO |
|||
3PO |
|||
| T22223-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: 3PO |
|||
Kinesis Rheodyne MXP Injection Valve; 6-Port; 2-Position - EACH |
|||
| CHR3715 | Scientific Laboratory Supplies | EACH | EUR 2582.55 |
4-POBN |
|||
| 561096 | MedKoo Biosciences | 5.0g | EUR 120 |
4-POBN |
|||
| MBS5776124-100mg | MyBiosource | 100(mg | EUR 145 |
4-POBN |
|||
| MBS5776124-5x100mg | MyBiosource | 5x100mg | EUR 500 |
4-POBN |
|||
| T26389-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: 4-POBN |
|||
4-POBN |
|||
| T26389-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: 4-POBN |
|||
4-POBN |
|||
| T26389-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: 4-POBN |
|||
4-POBN |
|||
| T26389-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: 4-POBN |
|||
4-POBN |
|||
| T26389-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: 4-POBN |
|||
Kinesis Rheodyne MXP Injection Valve; 10-Port; 2-Position - EACH |
|||
| CHR3717 | Scientific Laboratory Supplies | EACH | EUR 3576.15 |
Kinesis Rheodyne MXP Injection Valve; 6-Port; 2-Position; PEEK - EACH |
|||
| CHR3721 | Scientific Laboratory Supplies | EACH | EUR 2668.95 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) |
|||
| MBS648933-02mL | MyBiosource | 0.2mL | EUR 695 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) |
|||
| MBS648933-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (AP) |
|||
| MBS6315833-02mL | MyBiosource | 0.2mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (AP) |
|||
| MBS6315833-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (APC) |
|||
| MBS6315834-02mL | MyBiosource | 0.2mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (APC) |
|||
| MBS6315834-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (FITC) |
|||
| MBS6315836-02mL | MyBiosource | 0.2mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (FITC) |
|||
| MBS6315836-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (PE) |
|||
| MBS6315843-02mL | MyBiosource | 0.2mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (PE) |
|||
| MBS6315843-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
H-Thr(PO3H2)-OH |
|||
| E-3575.0001 | Bachem | 1.0g | EUR 254.4 |
|
Description: Sum Formula: C4H10NO6P; CAS# [1114-81-4] |
|||
H-Thr(PO3H2)-OH |
|||
| E-3575.0005 | Bachem | 5.0g | EUR 907.2 |
|
Description: Sum Formula: C4H10NO6P; CAS# [1114-81-4] |
|||
H-Ser(PO3H2)-OH |
|||
| F-2030.0005 | Bachem | 5.0g | EUR 166.8 |
|
Description: Sum Formula: C3H8NO6P; CAS# [407-41-0] |
|||
H-Ser(PO3H2)-OH |
|||
| F-2030.0025 | Bachem | 25.0g | EUR 529.2 |
|
Description: Sum Formula: C3H8NO6P; CAS# [407-41-0] |
|||
H-Ser(PO3H2)-OH |
|||
| F-2030.0100 | Bachem | 100.0g | EUR 1501.2 |
|
Description: Sum Formula: C3H8NO6P; CAS# [407-41-0] |
|||
H-Tyr(PO3H2)-OH |
|||
| F-4180.0005 | Bachem | 5.0g | EUR 340.8 |
|
Description: Sum Formula: C9H12NO6P; CAS# [21820-51-9] |
|||
H-Tyr(PO3H2)-OH |
|||
| F-4180.0025 | Bachem | 25.0g | EUR 1255.2 |
|
Description: Sum Formula: C9H12NO6P; CAS# [21820-51-9] |
|||
Kinesis Rheodyne ultralife Automated Valve; 2-Position; 6-Port; HP - EACH |
|||
| CHR3725 | Scientific Laboratory Supplies | EACH | EUR 2830.95 |
Kinesis Rheodyne ultralife Automated Valve; 2-Position; 10-Port; HP - EACH |
|||
| CHR3727 | Scientific Laboratory Supplies | EACH | EUR 4823.55 |
H-D-Ser(PO3H2)-OH |
|||
| F-2035.0500 | Bachem | 500.0mg | EUR 138 |
|
Description: Sum Formula: C3H8NO6P; CAS# [73913-63-0] |
|||
H-D-Ser(PO3H2)-OH |
|||
| F-2035.1000 | Bachem | 1.0g | EUR 224.4 |
|
Description: Sum Formula: C3H8NO6P; CAS# [73913-63-0] |
|||
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (Biotin) |
|||
| MBS6315835-02mL | MyBiosource | 0.2mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (Biotin) |
|||
| MBS6315835-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (Azide free) (HRP) |
|||
| MBS6315837-02mL | MyBiosource | 0.2mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (Azide free) (HRP) |
|||
| MBS6315837-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 405) |
|||
| MBS6315838-01mL | MyBiosource | 0.1mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 405) |
|||
| MBS6315838-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 490) |
|||
| MBS6315839-01mL | MyBiosource | 0.1mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 490) |
|||
| MBS6315839-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 550) |
|||
| MBS6315840-01mL | MyBiosource | 0.1mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 550) |
|||
| MBS6315840-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 650) |
|||
| MBS6315841-01mL | MyBiosource | 0.1mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 650) |
|||
| MBS6315841-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 750) |
|||
| MBS6315842-01mL | MyBiosource | 0.1mL | EUR 980 |
LGALS8, CT (LGALS8, Galectin-8, Po66 carbohydrate-binding protein, Prostate carcinoma tumor antigen 1) (MaxLight 750) |
|||
| MBS6315842-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
(Ser(PO3H2)273)-Nek11 (268-283) |
|||
| H-8312.0500 | Bachem | 0.5mg | EUR 360 |
|
Description: Sum Formula: C77H135N22O26PS |
|||
(Ser(PO3H2)273)-Nek11 (268-283) |
|||
| H-8312.1000 | Bachem | 1.0mg | EUR 594 |
|
Description: Sum Formula: C77H135N22O26PS |
|||
Fmoc-Tyr(PO3H2)-OH |
|||
| B-2470.0001 | Bachem | 1.0g | EUR 270 |
|
Description: Sum Formula: C24H22NO8P; CAS# [147762-53-6] |
|||
Fmoc-Tyr(PO3H2)-OH |
|||
| B-2470.0005 | Bachem | 5.0g | EUR 963.6 |
|
Description: Sum Formula: C24H22NO8P; CAS# [147762-53-6] |
|||
Fmoc-Ser(PO3H2)-OH |
|||
| B-2505.0001 | Bachem | 1.0g | EUR 313.2 |
|
Description: Sum Formula: C18H18NO8P; CAS# [158171-15-4] |
|||
Fmoc-Ser(PO3H2)-OH |
|||
| B-2505.0005 | Bachem | 5.0g | EUR 1110 |
|
Description: Sum Formula: C18H18NO8P; CAS# [158171-15-4] |
|||
Fmoc-Thr(PO3H2)-OH |
|||
| B-3425.0001 | Bachem | 1.0g | EUR 313.2 |
|
Description: Sum Formula: C19H20NO8P; CAS# [883726-90-7] |
|||
Fmoc-Thr(PO3H2)-OH |
|||
| B-3425.0005 | Bachem | 5.0g | EUR 1110 |
|
Description: Sum Formula: C19H20NO8P; CAS# [883726-90-7] |
|||
Boc-Tyr(PO3Me2)-OH |
|||
| B-3595.0001 | Bachem | 1.0g | EUR 327.6 |
|
Description: Sum Formula: C16H24NO8P; CAS# [92264-99-8] |
|||
Boc-Tyr(PO3Me2)-OH |
|||
| B-3595.0005 | Bachem | 5.0g | EUR 1197.6 |
|
Description: Sum Formula: C16H24NO8P; CAS# [92264-99-8] |
|||
p2ox Antibody |
|||
| CSB-PA682916XA01FWD-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Trametes pubescens (White-rot fungus) p2ox protein |
|||
p2ox Antibody |
|||
| CSB-PA682916XA01FWD-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Trametes pubescens (White-rot fungus) p2ox protein |
|||
p2ox Antibody |
|||
| CSB-PA809036XA01FUW-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Peniophora sp. (strain SG) (White-rot fungus) p2ox protein |
|||
p2ox Antibody |
|||
| CSB-PA809036XA01FUW-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Peniophora sp. (strain SG) (White-rot fungus) p2ox protein |
|||
p2ox Antibody |
|||
| CSB-PA765714XA01FUV-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Lyophyllum shimeji (Hon-shimeji) (Tricholoma shimeji) p2ox protein |
|||
p2ox Antibody |
|||
| CSB-PA765714XA01FUV-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Lyophyllum shimeji (Hon-shimeji) (Tricholoma shimeji) p2ox protein |
|||
P2OX Antibody |
|||
| CSB-PA303587XA01TPK-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Trametes versicolor (White-rot fungus) (Coriolus versicolor) P2OX protein |
|||
P2OX Antibody |
|||
| CSB-PA303587XA01TPK-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Trametes versicolor (White-rot fungus) (Coriolus versicolor) P2OX protein |
|||
PO2F3 rabbit pAb |
|||
| E28PT6917 | EnoGene | 100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PO2F3 rabbit pAb |
|||
| E44H15470 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
pO2 sensor cable |
|||
| 800096 | Lambda Laboratory Instruments | 1 Piece | Ask for price |
PO2F3 rabbit pAb |
|||
| UB-GEN-11375 | UpingBio | 100 ul | EUR 200 |
972Popular A |
|||
| 01030001 | Horron | 1 Each | Ask for price |
|
Description: Na, K, Cl |
|||
972Popular C |
|||
| 01030001-1 | Horron | 1 Each | Ask for price |
|
Description: Na, K, Cl, Ca, pH |
|||
Fmoc-Tyr(PO3Me2)-OH |
|||
| B-1990.0001 | Bachem | 1.0g | EUR 327.6 |
|
Description: Sum Formula: C26H26NO8P; CAS# [127633-36-7] |
|||
Fmoc-Tyr(PO3Me2)-OH |
|||
| B-1990.0005 | Bachem | 5.0g | EUR 1197.6 |
|
Description: Sum Formula: C26H26NO8P; CAS# [127633-36-7] |
|||
Fmoc-Tyr(PO3(MDPSE)2)-OH |
|||
| B-2910.0001 | Bachem | 1.0g | EUR 718.8 |
|
Description: Sum Formula: C54H54NO8PSi2; CAS# [158817-11-9] |
|||
Fmoc-Tyr(PO3(MDPSE)2)-OH |
|||
| B-2910.0005 | Bachem | 5.0g | EUR 2779.2 |
|
Description: Sum Formula: C54H54NO8PSi2; CAS# [158817-11-9] |
|||
PO3F2 Antibody |
|||
| C45597-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: PO3F2 Rabbit Polyclonal Antibody |
|||
PO3F2 Antibody |
|||
| C45597-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: PO3F2 Rabbit Polyclonal Antibody |
|||
PO3F3 Antibody |
|||
| C45598-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: PO3F3 Rabbit Polyclonal Antibody |
|||
PO3F3 Antibody |
|||
| C45598-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: PO3F3 Rabbit Polyclonal Antibody |
|||
PO5F2 Antibody |
|||
| C45599-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: PO5F2 Rabbit Polyclonal Antibody |
|||
PO5F2 Antibody |
|||
| C45599-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: PO5F2 Rabbit Polyclonal Antibody |
|||
(Ser(PO3H2)516)-Artemis (511-523) |
|||
| H-8318.0500 | Bachem | 0.5mg | EUR 254.4 |
|
Description: Sum Formula: C56H92N15O22P |
|||
The main findings showed that the public health system is the main provider of health services, mainly primary care, in Santo Antonio do Monte. Besides, the implementation of Lab for Innovation in Chronic Conditions showed the importance of building a Primary Health Care network in small municipalities.Community health agents and health managers played a fundamental role in the Primary Health Care network. The case study of Santo Antonio do Monte poses some challenges and lessons that clarify future interventions on building a Primary Health Care network that is essential to provide an adequate and longitudinal care to chronic conditions.